Curated metabolic health research from PubMed and leading YouTube channels
Subscribe via RSSShowing 1-5 of 5 articles
Research reveals that MLKL protein promotes liver cancer in obesity through mitochondrial dysfunction, suggesting new therapeutic targets for metabolic health.
Research shows glucosamine enhances autophagy and reduces liver fat, presenting a promising avenue for managing non-alcoholic fatty liver disease.
Diosgenin shows promise in reducing liver damage and lipid accumulation in NAFLD by inhibiting necroptosis, offering a natural approach to liver health.
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has surged, highlighting the need for better risk stratification and awareness, especially among South Asian populations.
A novel in vitro model mimics early mechanisms of metabolic dysfunction-associated steatotic liver disease, shedding light on lipid metabolism and inflammation.